In the News
BSRT announcements and Contribution to Events, Podcasts, Journals and Publications
BSRT Contributions to Events, Podcasts, and Publications
An interview with Maria Paola Chiesi, Vice-Chair of the Board of Chiesi Group, by Thomas Scheiwiller, Co-Founder and Partner, Biopharma Sustainability Roundtable
Investors’ ESG Expectations for Drug Developers
February 6, 2023
How biopharma can better communicate about ESG
June 14, 2022
Myrto Kontaxi and Victoria Emerick discuss the growing demand for better communication about ESG strategy and performance, and how the updated ESG Guidance can help both biopharma companies and investors respond.
Listen on SoundCloud or ApplePodcasts
Biopharma CEO Investor Forum
June 7-8, 2021
The Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum invite you to join nine leading leading biopharma CEOs for the first-ever sector-specific Biopharma CEO Investor Forum, June 7-8, 2021. CEOs from Catalent, GlaxoSmithKline, Incyte, Merck & Co., Moderna, Pfizer, Sanofi, Takeda, and UCB will share their Long-Term Plans for sustainable value creation with leading institutional investors and the wider stakeholder community.
Sandor Schoichet and Thomas Scheiwiller discuss the drive toward integrating environmental, social, and governance (ESG) topics into biopharma business planning, and communicating effectively about ESG performance with capital markets.
Listen on Soundcloud or Apple Podcasts
Fuerst, Michael, Rufenach, Steffen, Exl, Judith, Scheiwiller, Thomas. The Reporting Times, No 18, 2021.
Myrto Kontaxi, BSRT, and Brian Tomlinson, CECP, on integrating CECP’s Long-Term Plan Framework and the Biopharma Investor ESG Communications Guidance to support sustainable long-term strategy for biopharma.
Pharmaceutical Executive
Sustainability columns by Sandor Schoichet
Why ESG Performance Metrics Matter
March 11, 2021
A New Year for Sustainable Governance
January 13, 2021
Biopharma Joins Race to Net-Zero Carbon Emissions
December 11, 2020
Synthetic Biology and the Environment
November 16, 2020
The Regulatory Engagement Conundrum
October 14, 2020
Sustainable Long-Term Planning
September 11, 2020
Pharma’s Digital-Trust Mandate
August 7, 2020
A Sustainable Response to COVID-19
July 7, 2020
Better ESG Communication with Investors
June 12, 2020
Biopharma Sustainability Considered Essential
May 18, 2020